VAP - Ventilator Associated Pneumonia Clinical Trial
Official title:
Effects of Oral Care With 3% Hydrogen Peroxide (Oroxid®) on the Lower Respiratory Tract Microbial Colonisation in Mechanically Ventilated Adult Critically Ill Patients (HyPer-MICROBE Trial); a Single-centre, Randomised, Controlled Trial
HyPerMICROBE is a single-centre, controlled, randomised, prospective, superiority clinical trial to compare the efficacy of daily oral care with 3% hydrogen peroxide (Oroxid®) versus standard of care (0.2% chlorhexidine digluconate) on the cumulative incidence of lower respiratory tract microbial colonisation in mechanically ventilated adult critically ill patients.
Rationale: Ventilator-associated pneumonia (VAP) is the most common hospital-acquired infection (HAI) in the intensive care unit (ICU), and its impact is very high in terms of morbidity, length of hospital stay and overall costs. Chlorhexidine for oral care in critically ill has no clear impact on VAP rates and may cause harm. 3% hydrogen peroxide (Oroxid) could be a promising substitute. Aim: To test effectivity and safety of 3% hydrogen peroxide solution on ventilator-associated complications Design: Prospective, single center, parallel group randomised controlled trial. Subjects: ICU patients (general ICU) Treatment in the intervention group: daily oral care with 3% hydrogen peroxide Control group: Standard-of-care protocolised daily oral care with 0,2% chlorhexidine Primary outcome: Cumulative incidence of lower respiratory tract microbial colonisation analysed by Kaplan-Maier method, censored in the case of ICU discharge or extubation > 24h. Secondary and exploratory outcomes: Differences in the relative risk of infection related ventilator-associated complications, antibiotic (ATB) consumption analysis, intraoral complications, reported using the Bedside oral exam (BOE) score, validated and adopted for ICU, length of ICU stay in days (time frame: at 3 months), number of ventilator-free days (time frame: at 28 days); that is, number of days, out of 28 days after admission, that patient has not been supported by mechanical ventilation ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05575050 -
Impact of Teeth Brushing in Ventilated COVID-19 Patients.
|
N/A | |
| Not yet recruiting |
NCT06035796 -
Performance Study of Targeted Sequencing Technology for VAP
|
||
| Not yet recruiting |
NCT06073834 -
LUNG INFECTION IN ICU (LUNG-I3)
|
||
| Not yet recruiting |
NCT04955821 -
Early Identification of Pathogens in Children With Respiratory Tract Infection by Mechanical Ventilation Using mNGS
|
||
| Completed |
NCT04038814 -
The Effectiveness of the Modified Bundle in the Prevention of VAP.
|
||
| Completed |
NCT05230472 -
Effect of Statin Therapy on Mortality in Patients With Ventilator Associated Pneumonia
|
Phase 4 | |
| Not yet recruiting |
NCT05738928 -
Microbiological Profile of VAP Patients in Respiratory ICU
|
||
| Completed |
NCT05176353 -
Ventilator-associated Pneumonia (VAP) Diagnostic Stewardship Trial
|
N/A | |
| Recruiting |
NCT05952648 -
HAP/VAP Diagnosis in Critically Ill Septic Patients Using a Multiplex PCR Array
|
N/A |